Pertussis in the young infant

S D Hampl1, L C Olson

  • 1Department of Pediatrics, University of Missouri-Kansas City, School of Medicine, USA.

Seminars in Respiratory Infections
|March 1, 1995
PubMed

Insights

Waning immunity and subclinical pertussis (whooping cough) in adults fuel outbreaks, especially in infants. Current vaccines need improvement to combat the resurgence of this highly contagious respiratory illness.

Area of Science:

  • Communicable diseases
  • Immunology
  • Pediatrics

Background:

  • Pertussis (whooping cough) is a highly contagious respiratory illness with variable severity, decreasing with age.
  • Adults with waning immunity can transmit subclinical pertussis to unvaccinated or under-vaccinated children.
  • Despite high immunization rates, pertussis activity persists, posing significant risks to infants.

Purpose of the Study:

  • To highlight the ongoing challenge of pertussis transmission.
  • To emphasize the vulnerability of young infants to severe pertussis complications.
  • To underscore the need for enhanced pertussis vaccine strategies.

Main Methods:

  • Review of pertussis epidemiology and transmission dynamics.
  • Analysis of disease severity and complications in different age groups.
  • Evaluation of current immunization strategies and their limitations.

Main Results:

  • Infants under 2 months face the highest attack rates, morbidity, and mortality from pertussis.
  • Serious complications include apnea, pneumonia, and encephalopathy, prolonging illness in infants.
  • Pertussis resurgence is observed despite widespread active immunization, indicating transmission in immunized populations and subclinical adult reservoirs.

Conclusions:

  • Subclinical pertussis in adults acts as a reservoir for transmission to vulnerable infants.
  • The current pertussis vaccine immunization strategy requires re-evaluation due to disease resurgence.
  • More effective vaccines are needed to control pertussis transmission and protect infants.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...